Lightnews — Scholar-powered news

Reposted by Ebenn

Kat Holt @katholt.bsky.social · Jul 1

I'm super happy to share this preprint on ‘Distribution of capsule and O types in #Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: meta-analysis of genome-predicted serotype prevalence and potential vaccine coverage’
doi.org/10.1101/2025...

Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: meta-analysis of genome-predicted serotype prevalence and potential vaccine coverage

Background: Klebsiella pneumoniae causes ~20% of sepsis in neonates, with ~40% crude mortality. A vaccine administered to pregnant women, protecting against 70% of K. pneumoniae infections, could aver...

doi.org

1 25 33

Ebenn @efosternyarko.bsky.social · 18d

Honoured + super grateful to give an oral talk on efforts by #PulseNETAfrica to enhance capacity of public health labs across Africa for cholera mgt + a poster describing investigation of a neonatal kleb pneumoniae ST39 outbreak in a rural hospital in the Gambia at #IMMEM XIV in beautiful Porto 🇵🇹

ESCMID @escmid.bsky.social · 20d

We are on to day 3 of the #IMMEM conference in Porto after some great talks and the first poster session featuring the research that's being done by our community! Today we'll be covering environmental surveillance for #ID and #AMR and how best to share pathogen data. #IDsky #clinmicro

2 5

Reposted by Ebenn

Louise Roer @louiseroer.bsky.social · 20d

✨Célia Souque just showcased the outcomes of the 12th Microbial Bioinformatics Hackathon at IMMEM XIV.

She brilliantly presented the first sneak-peek of PORT – Plasmid Outbreak Reporting Tool! 🧬
Looking forward to continuing this collaboration with PORT!

#IMMEM #Hackathon #Plasmids #ESGEM #ESGMAP

1 8 24

Reposted by Ebenn

Emma Doughty @emmadoughty.bsky.social · Aug 14

I’ve got something exciting to share. After years of working with labs around the world, I’m starting something new!

I’ve seen how many labs want to do more with genomics, but the path forward isn’t always clear. The process is complex, and without the right guidance, it’s easy to get stuck.

At the top there is a map of the world showing pins and illustrations of hospitals and laboratories. The text reads

SEQUITY MAKES GENOMICS WORK FOR YOU
Developing solutions that work with your unique lab, challenges and epidemiology
CONTEXT-DRIVEN
Delivering outcomes aligned with your objectives
GOAL-ORIENTED

This image is text only. This reads,
YOUR PARTNER FOR GENOMICS SUCCESS
STRATEGY
Figuring out what will work in your unique context
RESOURCES
Developing everything- from bioinformatics workflows to SOPs
TRAINING
Ensuring you have the knowledge and skills to deliver
ON-DEMAND SUPPORT
Ongoing support through the day-to-day

An abstract image at the bottom shows scientists working through a process, generating ideas. The text at the top reads,
FROM IDEA TO IMPACT
END-TO-END SUPPORT
From study design to sample, wet lab, bioinformatic, and reporting

VALUED-OUTCOMES
Unlock information and real-world impact

4 3 5

Ebenn @efosternyarko.bsky.social · Jul 1

Check out our tour-de-force study exploring Klebsiella capsules and O types in neonatal sepsis isolates from Asia & Africa. An excellent demonstration of how collaboration is essential to move the field forward & realise the benefits of genomics for public health & clinical micro!

Kat Holt @katholt.bsky.social · Jul 1

I'm super happy to share this preprint on ‘Distribution of capsule and O types in #Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: meta-analysis of genome-predicted serotype prevalence and potential vaccine coverage’
doi.org/10.1101/2025...

Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: meta-analysis of genome-predicted serotype prevalence and potential vaccine coverage

Background: Klebsiella pneumoniae causes ~20% of sepsis in neonates, with ~40% crude mortality. A vaccine administered to pregnant women, protecting against 70% of K. pneumoniae infections, could aver...

doi.org

1 3

Ebenn @efosternyarko.bsky.social · May 21

Thanks for your kind words, support and encouragement every step of the way, @katholt.bsky.social!

1

Reposted by Ebenn

Kat Holt @katholt.bsky.social · May 21

Super talk from @efosternyarko.bsky.social @lshtmamrcentre.bsky.social on nanopore based sequencing of cholera across Africa, with PulseNet Africa partners

#ABPHM25

www.biorxiv.org/content/10.1...

Ebenezer Foster-Nyarko presenting his introductory slide on cholera genomics at the ABPHM 2025 conference

1 7 21

Reposted by Ebenn

KlebNET-GSP @klebnet.bsky.social · May 21

We are pleased to launch the KlebNET Genomic Epidemiology Consortium!

We aim to build a public metadata repository; systematic risk framework for global genomic surveillance; and genomic epi reviews for high-impact #Klebsiella clones.

Join us here:
klebnet.org/klebnet-gsp-...

#ABPHM25

KlebNET-GSP

klebnet.org

17 13

Ebenn @efosternyarko.bsky.social · Nov 26

You both were such amazing hosts - thanks for an excellent conference! 🎉

1

Reposted by Ebenn

Chiara Crestani @chcrestani.bsky.social · Nov 23

Thanks @sylvainbrisse.bsky.social for involving me in KlebNET-GSP as project manager 3y ago, it was a very enriching experience! Thanks to all the attendees of #KLEBS2024 for making this a great success, it was our best reward! And thanks to the @gatesfoundation.bsky.social for making it possible!

sylvain Brisse @sylvainbrisse.bsky.social · Nov 22

#KLEBS2024 has just finished, big thanks to @chcrestani.bsky.social for her fantastic help in organizing

3 6 21

Reposted by Ebenn

Kat Holt @katholt.bsky.social · Feb 28

JOB ALERT!
Come work with me at LSHTM to investigate transmission of Klebsiella pneumoniae in neonatal units in Africa using bioinformatics and genomic epi.
Great team, Gates funded, £44-50k/yr, 1-year postdoc to start with possibilities to extend. Closing March 26.
jobs.lshtm.ac.uk/vacancy.aspx...

1 28 12